placeholder image

DR Rick Liu

Positions

  • Gene Engineering (Viral vector and nanoparticle)
  • Gene Therapy (Eye Research)
  • Ocular neovascularisation (AMD, Diabetic retinopathy)

Overview

OverviewText1

  • Dr Liu is a Research Fellow in Centre for Eye Research Australia and Department of Ophthalmology at University of Melbourne. Dr Liu completed his doctorate in biochemistry/gene engineering at Kaohsiung Medical University (Taiwan, 2006) and postdoctoral training in Pharmacology/Vascular Biology from O’Brien Institute from 2009 to 2011. His current research has focus on understanding the angiogenesis within the eye (termed ocular neovascularisation) and building a platform of research based on angiogenesis for drug discovery as well as ocular gene therapy, with a particular interest in directing future work into clinical research. Currently, Dr Liu is leading a team charged with developing gene therapies to prevent and delay blindness in major eye diseases that result from pathological neovascularisation.   

Affiliation

Member of

  • Tissue Engineering and Regenerative Medicine International Society (TERMIS). Full Member 2013 - 2016
  • American Society of Gene & Cell Therapy (ASGCT). Associated Member 2013 - 2015
  • Australasian Gene Therapy Society. Full Member 2013
  • the Association for Research in Vision and Ophthalmology (ARVO). Full Member 2013

Publications

Selected publications

Research

Additional Grant Information

  • 2014 NHMRC Project Grant (CIB). New treatment to block retinal blood vessel growth avoiding eye surgery. 2014 Angior Family Foundation (Chief Investigator). A novel topical medication to prevent loss of vision in a degenerative eye disease in the elderly. 2014 SSF-International Collaboration Project, China. Identification of Anthocyanin types controlling the extent of myopia and the direct mechanism of action. 2013 ORIA Research Grant (Chief Investigator). Gene delivery of a new drug for aberrant development of blood vessels. 2013University of Melbourne Early Career Researcher Fellowship (Chief Investigator). Vasostatin: A potential new drug for the treatment of vision loss.    

Awards

Education and training

  • PhD, Kaohsiung Medical University 2006
  • BSc, 2000

Awards and honors

  • The CASS Foundation Travel Award, 2014
  • 2013 ZOC/SKLO Travel Award, 2013
  • Harold Mitchell Travel Award, 2013
  • Young Investigator Award, International Symposium of Materials on Regenerated Medicine (2012 ISOMRM), 2012

Supervision

Available for supervision

  • Y